Table 2.
Metabolic effects of the Ma-Pi 2 dietary intervention after variable periods of time
Metabolic parameters | Duration of Ma-Pi 2 intervention | Effect |
Body mass index | 3 wk-6 mo | ↓ |
Body weight (kg) | 3 wk-6 mo | ↓ |
Body fat mass (%) | 3 wk-6 mo | ↓ |
Body fat free mass (%) | 3 wk-6 mo | ↔ |
Fasting glucose (mg/dL) | 3 wk-6 mo | ↓ |
Fasting insulin (mIU/mL) | 3 wk | ↓ |
HbA1c | 3 wk-6 mo | ↓ |
HOMA-R index | 3 wk-6 mo | ↓ |
Triglycerides (mg/dL) | 3 wk-6 mo | ↓ |
Total cholesterol (mg/dL) | 3 wk-6 mo | ↓ |
HDL-cholesterol (mg/dL) | 3 wk-6 mo | ↔ |
LDL-cholesterol (mg/dL) | 3 wk-6 mo | ↓ |
Systolic blood pressure (mmHg) | 3 wk-6 mo | ↓ |
Diastolic blood pressure (mmHg) | 3 wk | ↓ |
Urinary pH | 3 wk | ↑ |
Serum anion gap (mEq/L) | 3 wk | ↓ |
Serum bicarbonate (mEq/L) | 3 wk | ↑ |
Tumor necrosis factor alpha (ng/mL) | 3 wk | ↓ |
Interleukin 6 (pg/mL) | 3 wk | ↔ |
Insulin-like growth factor 1 (ng/mL) | ↓ |
Taken from the results of studies investigating the Ma-Pi 2 diet in men and women with type 2 diabetes over variable periods. ↑: Increase; ↓: Decrease; ↔: No effect; HbA1c: Glycosylated hemoglobin; HDL: High-density lipoprotein; LDL: Low-density lipoprotein.